Literature DB >> 10516617

Brain metabolic alterations in Cushing's syndrome as monitored by proton magnetic resonance spectroscopy.

A Khiat1, C Bard, A Lacroix, J Rousseau, Y Boulanger.   

Abstract

Proton magnetic resonance spectroscopy ((1)H MRS) was used to evaluate changes in cerebral metabolites in 13 patients with Cushing's syndrome (including seven with pituitary corticotroph adenomas and six with primary adrenal disease) as compared to 40 normal subjects. Data were recorded in the frontal, thalamic and temporal areas; quantification of the MRS signals demonstrated a statistically significant decrease of the Cho/Cr ratio in the frontal and thalamic areas but not in the temporal area for patients with Cushing's syndrome. The largest decrease in Cho/Cr was measured in the thalamic area of patients with a Cushing's syndrome secondary to an adrenal disease. No statistically significant changes in the NAA/Cr ratio were measured in any of the areas studied. These results suggest that the quantification of choline levels could be helpful for monitoring the cerebral metabolite alterations in patients with hypercortisolism. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516617     DOI: 10.1002/(sici)1099-1492(199910)12:6<357::aid-nbm584>3.0.co;2-u

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  8 in total

Review 1.  The application of NMR-based metabonomics in neurological disorders.

Authors:  Elaine Holmes; Tsz M Tsang; Sarah J Tabrizi
Journal:  NeuroRx       Date:  2006-07

2.  Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.

Authors:  Iris Crespo; Alicia Santos; Beatriz Gómez-Ansón; Olga López-Mourelo; Patricia Pires; Yolanda Vives-Gilabert; Susan M Webb; Eugenia Resmini
Journal:  Endocrine       Date:  2016-04-21       Impact factor: 3.633

3.  Cross-sectional and 35-year longitudinal assessment of salivary cortisol and cognitive functioning: the Vietnam Era twin study of aging.

Authors:  Carol E Franz; Robert C O'Brien; Richard L Hauger; Sally P Mendoza; Matthew S Panizzon; Elizabeth Prom-Wormley; Lindon J Eaves; Kristen Jacobson; Michael J Lyons; Sonia Lupien; Dirk Hellhammer; Hong Xian; William S Kremen
Journal:  Psychoneuroendocrinology       Date:  2011-02-03       Impact factor: 4.905

4.  Impact of chronic hypercortisolemia on affective processing.

Authors:  Scott A Langenecker; Sara L Weisenbach; Bruno Giordani; Emily M Briceño; Leslie M Guidotti Breting; Michael-Paul Schallmo; Hadia M Leon; Douglas C Noll; Jon-Kar Zubieta; David E Schteingart; Monica N Starkman
Journal:  Neuropharmacology       Date:  2011-07-23       Impact factor: 5.250

Review 5.  Genomic and epigenomic mechanisms of glucocorticoids in the brain.

Authors:  Jason D Gray; Joshua F Kogan; Jordan Marrocco; Bruce S McEwen
Journal:  Nat Rev Endocrinol       Date:  2017-09-01       Impact factor: 43.330

Review 6.  Dynamic changes of views on the brain changes of Cushing's syndrome using different computer-assisted tool.

Authors:  Lu Gao; Lu Liu; Lin Shi; Yishan Luo; Zihao Wang; Xiaopeng Guo; Bing Xing
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

Review 7.  Quality of Life in Patients With Cushing's Disease.

Authors:  Alicia Santos; Eugenia Resmini; Mª Antonia Martínez Momblán; Elena Valassi; Luciana Martel; Susan M Webb
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-11       Impact factor: 5.555

Review 8.  Metabolomics-A Promising Approach to Pituitary Adenomas.

Authors:  Oana Pînzariu; Bogdan Georgescu; Carmen E Georgescu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-17       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.